| Literature DB >> 25488840 |
Ryota Nabika1, Takashi L Suyama2, Andrew M Hau2, Ryosuke Misu1, Hiroaki Ohno1, Jane E Ishmael2, Kerry L McPhail2, Shinya Oishi3, Nobutaka Fujii4.
Abstract
Coibamide A is a highly potent antiproliferative cyclic depsipeptide, which was originally isolated from a Panamanian marine cyanobacterium. In this study, the synthesis of coibamide A has been investigated using Fmoc-based solid-phase peptide synthesis followed by the cleavage of the resulting linear peptide from the resin and its subsequent macrolactonization. The peptide sequence of the linear coibamide A precursor was constructed on a solid-support following the optimization of the coupling conditions, where numerous coupling agents were evaluated. The macrocyclization of the resulting linear peptide provided the [d-MeAla(11)]-epimer of coibamide A, which exhibited nanomolar cytotoxic activity towards a number of human cancer cell lines.Entities:
Keywords: Antiproliferative peptide; Coibamide A; Depsipeptide; N-Methylamino acid
Mesh:
Substances:
Year: 2014 PMID: 25488840 PMCID: PMC4342349 DOI: 10.1016/j.bmcl.2014.11.044
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823